Data_Sheet_1_Burden and trends of stroke attributable to dietary risk factors from 1990 to 2019 in the Belt and Road Initiative countries: an analysis from the global burden of dis... by Yue Zhang (30585)

“…The ASR of DALYs for diet-induced stroke decreased greater in females than in males. For those aged 50–74, the DALYs for stroke due to dietary risk factors in all other member countries of the “B&R” showed a decreasing trend, except for the Philippines, which rose (AAPC = 2.13, 95%CI: 1.40–2.87%) and Turkmenistan, which remained stable (AAPC = 0.05, 95%CI: −0.43–0.33%).…”

Table_1_Impact of foliar application of syringic acid on tomato (Solanum lycopersicum L.) under heavy metal stress-insights into nutrient uptake, redox homeostasis, oxidative stres... by Jing Ma (24574)

“…Results from the present study showed that the increasing levels of Pb in the soil decreased non-significantly (P < 0.05) shoot length, root length, shoot fresh weight, root fresh weight, shoot dry weight, root dry weight, chlorophyll-a, chlorophyll-b, total chlorophyll, carotenoid content, net photosynthesis, stomatal conductance, transpiration rate, soluble sugar, reducing sugar, non-reducing sugar contents, calcium (Ca²⁺), magnesium (Mg²⁺), iron (Fe²⁺), and phosphorus (P) contents in the roots and shoots of the plants. …”

Sleep Duration and Cancer in the NIH-AARP Diet and Health Study Cohort by Fangyi Gu (266663)

“…A decreased ovarian cancer risk (HR_{≥ 9 vs. 7–8 hours} = 0.50; 95%CI:0.26–0.97) and an increased NHL risk (HR_{≥ 9 vs. 7–8 hours} = 1.45; 95%CI:1.00–2.11) were observed among long sleepers.…”

Table 4_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

“…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. …”

Supplementary file 1_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period... by Wubing Cao (20821589)

“…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. …”

Table 2_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

“…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. …”

Table 1_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

“…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. …”

USUV replicates in STAT1-sufficient peripheral tissues leading to spleen and liver pathology. by Amy N. Nelson (21763146)

“…<b>(H)</b> Immunostaining of liver tissue harvested from a <i>Stat1</i>^-/- mouse using the histiocyte marker CD68, anti-JEV NS3 to mark USUV infection, and DAPI with a 50 µm scale bar. …”

Table 3_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

“…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. …”

Determination of whole genome attractors for atRA and DMSO responses. by Masa Tsuchiya (78226)

“…<p>Temporal probability distributions of (A) <i>r_v</i> and (B) <i>I</i> for atRA (upper panel) and DMSO (lower panel) for <i>n</i> = 10, 50, 200 genes randomly selected from whole genome. …”

Quantitative changes in <i>Clostridium thermocellum</i> cellulosome composition in response to carbon substrate – Part II. by Babu Raman (264806)

“…Structural, catalytic and/or binding module information was obtained from the following sources: <a href="http://pfam.sanger.ac.uk/" target="_blank">http://pfam.sanger.ac.uk/</a>; <a href="http://www.cazy.org/" target="_blank">http://www.cazy.org/</a>; <a href="http://genome.ornl.gov/microbial/cthe/" target="_blank">http://genome.ornl.gov/microbial/cthe/</a>. …”

Table 7_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

“…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. …”

Supplementary file 2_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period... by Wubing Cao (20821589)

“…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. …”

METH treatment induced different changes in Lmx and Msx gene expression in midbrain. by Irina N. Krasnova (223517)

“…In contrast, METH caused decreases in Msx2 expression in the SSM group (D). …”

TcdB3 has reduced binding to CSPG4. by Zhenrui Pan (10047214)

“…The percentage of rounded cells were plotted over toxin concentrations. Their CR50 were measured and plotted in a bar chart (I). …”

Optimization of sample collection, extraction and ELISA protocols to measure cortisol level in zebrafish larvae. by Chen-Min Yeh (225051)

“…(<b>E</b>) An incubation of HRP with TMB at a pH level of 4.5 gives the highest signal intensity, whereas signal detection decreases sharply at pH levels lower and higher than 3.5 and 6, respectively. …”

DataSheet1_Identification of immune-related biomarkers for intracerebral hemorrhage diagnosis based on RNA sequencing and machine learning.docx by Congxia Bai (11728634)

“…Background<p>Intracerebral hemorrhage (ICH) is a severe stroke subtype with high morbidity, disability, and mortality rates. …”

DataSheet1_Curcumin Ameliorates Cardiac Fibrosis by Regulating Macrophage-Fibroblast Crosstalk via IL18-P-SMAD2/3 Signaling Pathway Inhibition.DOCX by Jing Zhao (21160)

“…<p>Ethnopharmacological relevance: Curcumin is a bright yellow chemical produced by plants of the Curcuma longa species. …”

Table_2_“Longitudinal Fecal Microbiome Study of Total Body Irradiated Mice Treated With Radiation Mitigators Identifies Bacterial Associations With Survival”.xlsx by Kelvin Li (158276)

“…Survival improved relative to control (30.0%) for G-CSF (80%, p-value = 0.025), G-CSF/JP4-039 (70%, p-value = 0.084), but not for JP4-039 (50.0%). In the second experiment, mice were administered mitigation drugs “inhibiting programmed cell death” pathways: JP4-039 (anti-apoptosis), necrostatin-1 (anti-necroptosis), and baicalein (anti-ferroptosis), in eight combinations. …”

FIGURE 3 from Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial–mesenchymal Transition in Aggressive Variant Prostate Cancers by Taraswi Mitra Ghosh (16616796)

“…<b>B,</b> Apoptosis (caspase 3/7 assay): Levels of caspase 3/7 enzyme (a marker of apoptosis) activities measured followed CONV-TOPO, CONV-DTX, METRO-TOPO, and the combination of CONV-DTX + METRO-TOPO 72 hours treatment. …”